GE HealthCare Technologies Inc. GEHC
- Market cap
- $29.9B
- P/E
- 15.3×
Follow GEHC
GE HealthCare Technologies Inc. (GEHC) Price to free cash flow
As of 25 September 2026, GE HealthCare Technologies Inc. (GEHC) trades at a price to free cash flow of 19.1×. Over the past ten years it has ranged from 13.9× (January 2023) to 36.0× (December 2022); the current reading is higher than 21% of that period. That is below the Medical Devices industry median of 22.5× and in line with the Healthcare sector median of 19.5×.
Price to free cash flow, daily
Annual
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2025 | 24.9× | 8.33% |
| FY2024 | 22.9× | 13.22% |
| FY2023 | 20.3× | 45.68% |
| FY2022 | 13.9× | (61.40%) |
| FY2021 | 36.0× | 0.00% |
| FY2020 | 36.0× | 0.00% |
| FY2019 | 36.0× | — |
Quarterly
| Period | Price to free cash flow | Change |
|---|---|---|
| Jun 2026 | 18.4× | (14.06%) |
| Mar 2026 | 21.4× | (14.02%) |
| Dec 2025 | 24.9× | 1.59% |
| Sep 2025 | 24.5× | 13.38% |
| 14 more quarters | Free account |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 6.0× |
| PHG Koninklijke Philips N.V. compare | 12.9× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 16.9× |
| BSX Boston Scientific Corporation compare | 17.8× |
| GEHC GE HealthCare Technologies Inc. | 19.1× |
| STE STERIS plc compare | 21.8× |
| DXCM DexCom, Inc. compare | 23.6× |
| EW Edwards Lifesciences Corporation compare | 35.4× |
| PEN Penumbra, Inc. compare | 58.1× |
| Medical Devices industry median | 22.5× |
| Healthcare sector median | 19.5× |
| Market median | 14.0× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on GEHC
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement